诊断学理论与实践

诊断学理论与实践 >

2020 , Vol. 19 >Issue 02: 191 - 194

DOI: https://doi.org/10.16150/j.1671-2870.2020.02.018

病例报告

以反复上消化道出血为首发表现的套细胞淋巴瘤一例

展开
  • 上海交通大学医学院附属瑞金医院北院消化内科,上海 201801

收稿日期: 2019-06-10

  网络出版日期: 2020-04-25

收起

本文引用格式

丁燕飞, 陈平, 罗方秀, 吴云林 . 以反复上消化道出血为首发表现的套细胞淋巴瘤一例[J]. 诊断学理论与实践, 2020 , 19(02) : 191 -194 . DOI: 10.16150/j.1671-2870.2020.02.018

参考文献

[1] Fakhri B, Kahl B. Current and emerging treatment options for mantle cell lymphoma[J]. Ther Adv Hematol, 2017, 8(8):223-234.
[2] Vose JM. Mantle cell lymphoma: 2017 update on diagnosis, risk-stratification, and clinical management[J]. Am J Hematol, 2017, 92(8):806-813.
[3] 陈灏珠, 林果为, 王吉耀, 等. 实用内科学[M]. 14版. 北京: 人民卫生出版社, 2013:2438-2439.
[4] Matutes E, Parry-Jones N, Brito-Babapulle V, et al. The leukemic presentation of mantle-cell lymphoma: disease features and prognostic factors in 58 patients[J]. Leuk Lymphoma, 2004, 45(10):2007-2015.
[5] 平凌燕, 郑文, 王小沛, 等. 98例套细胞淋巴瘤临床特点及预后分析[J]. 中国肿瘤临床, 2014, 41(19):1234-1238.
[6] Tiemann M, Schrader C, Klapper W, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network[J]. Br J Haematol, 2005, 131(1):29-38.
[7] Dasappa L, Suresh Babu MC, Sirsath NT, et al. Primary gastrointestinal mantle cell lymphoma: a retrospective study[J]. J Gastrointest Cancer, 2014, 45(4):481-486.
[8] Khuroo MS, Khwaja SF, Rather A, et al. Clinicopathological profile of gastrointestinal lymphomas in Kashmir[J]. Indian J Med Paediatr Oncol, 2016, 37(4):251-255.
[9] Howell JM, Auer-Grzesiak I, Zhang J, et al. Increasing incidence rates, distribution and histological characteristics of primary gastrointestinal non-Hodgkin lymphoma in a North American population[J]. Can J Gastroenterol, 2012, 26(7):452-456.
[10] Radić-Krišto D, Planinc-Peraica A, Ostojić S, et al. Primary gastrointestinal non-Hodgkin lymphoma in adults: clinicopathologic and survival characteristics[J]. Coll Antropol, 2010, 34(2):413-417.
[11] Shannon EM, MacQueen IT, Miller JM, et al. Management of Primary Gastrointestinal Non-Hodgkin Lymphomas: a Population-Based Survival Analysis[J]. J Gastrointest Surg, 2016, 20(6):1141-1149.
[12] Baheti AD, Tirumani SH, Sewatkar R, et al. MDCT of extranodal mantle cell lymphoma: a single institute experience[J]. Abdom Imaging, 2015, 40(6):1693-1699.
[13] Hu C, Yi C, Dai X. Clinical study of 31 patients with primary gastric mucosa-associated lymphoid tissue lymphoma[J]. J Gastroenterol Hepatol, 2006, 21(4):722-726.
[14] Martin P, Ghione P, Dreyling M. Mantle cell lymphoma - Current standards of care and future directions[J]. Cancer Treat Rev, 2017, 58:51-60.
[15] Spurgeon SE, Till BG, Martin P, et al. Recommendations for Clinical Trial Development in Mantle Cell Lymphoma[J]. J Natl Cancer Inst, 2016, 109(1):263.
[16] Fakhri B, Kahl B. Current and emerging treatment options for mantle cell lymphoma[J]. Ther Adv Hematol, 2017, 8(8):223-234.
[17] Rule S, Dreyling M, Goy A, et al. Outcomes in 370 patients with mantle cell lymphoma treated with ibrutinib: a pooled analysis from three open-label studies[J]. Br J Haematol, 2017, 179(3):430-438.
Options
文章导航

/

〈 〉